4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-23-023950
Chief Financial Officer sold 15,000 shares at $36.20 ($543,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Myszkowski Kenneth Allen Chief Financial Officer | 2023-06-27 | Sale | −15,000 | $36.20 | $543,000 | 381,704 | D |
| Open-market sales · 15,000 sh · avg $36.20 · $543,000 | |||||||
Loading xslF345X04/wf-form4_168807847193372.xml…